Why Illumina’s Latest Move Has Investors Watching Closely Illumina (ILMN) just deepened its bet on clinical whole genome sequencing by investing in and partnering with MyOme, backing a large Proactive ...
Researchers from Nazarbayev University's National Laboratory created the first large-scale, high-quality genotyping dataset ...
The GUARDIAN study has been recognized as one of the most impactful scientific contributions published across all JAMA journals this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback